Ling Ma

Trilaciclib prior to chemotherapy in metastatic triple-negative breast cancer: final efficacy and subgroup analysis from a randomized phase II study

A. Tan, T. Pluard, M. Danso, 2021 .

Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study.

M. Burotto, L. Fallowfield, S. Margolin, 2021, European journal of cancer.

Does GRASP affect DCE-MRI for assessing response to neoadjuvant chemotherapy in patients with esophageal cancer?

J. Qu, Hailiang Li, Zhaoqi Wang, 2019 .

[Application of Conditioning Regimen with Busulfan and Cyclophosphamide in Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma].

Jin Zhou, C. Fu, Deipei Wu, 2021, Zhongguo shi yan xue ye xue za zhi.

DCE-MRI radiomics nomogram can predict response to neoadjuvant chemotherapy in esophageal cancer

I. Kamel, J. Qu, Hailiang Li, 2022, Discover Oncology.

[Efficacy and safety study of subcutaneous injection of bortezomib in the treatment of de novo patients with multiple myeloma].

A. Sun, Qian Wu, C. Fu, 2013, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

PDD与PAD方案治疗初治多发性骨髓瘤患者的疗效和安全性比较

A. Sun, Depei Wu, C. Fu, 2015, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.